AGENUS INC (25) | Intellectual Property (4)

Browse by Subcategory

License Agreements (4)

Recent Contracts

License, Development and Commercialization Agreement, dated May 17, 2021, by and between Agenus Inc. and Bristol Myers Squibb Company (Filed With SEC on August 9, 2021)
License Agreement dated December 20, 2018, by and between Agenus Inc. and Gilead Sciences, Inc (Filed With SEC on March 18, 2019)
Option and License Agreement (AGEN1223) dated December 20, 2018, by and between Agenus Inc. and Gilead Sciences, Inc (Filed With SEC on March 18, 2019)
Option and License Agreement (AGEN2373) dated December 20, 2018, by and between Agenus Inc. and Gilead Sciences, Inc (Filed With SEC on March 18, 2019)